Literature DB >> 20040703

Safety considerations and potential interactions of vitamins: should vitamins be considered drugs?

Alexander L Rogovik1, Sunita Vohra, Ran D Goldman.   

Abstract

OBJECTIVE: To examine adverse effects, adverse events, and potential interactions of vitamins in light of their current prevalence of use, and to discuss whether vitamins should be considered over-the-counter drugs or natural health products/dietary supplements. DATA SOURCES: We performed a MEDLINE/PubMed search, explored 4 online databases (Medline Plus, Drug Digest, Natural Medicine Comprehensive Database, and the database of the University of Maryland), and examined reference lists of included studies published from 1966 through October 2009. STUDY SELECTION AND DATA EXTRACTION: The studies were reviewed, with an emphasis on randomized controlled clinical trials. We included articles with the most clinically important information with regard to adverse events and interactions. DATA SYNTHESIS: Vitamins are used by over one third of the North American population. Vitamins have documented adverse effects and toxicities, and most have documented interactions with drugs. While some vitamins (biotin, pantothenic acid, riboflavin, thiamine, vitamin B(12), vitamin K) have minor and reversible adverse effects, others, such as fat-soluble vitamins (A, E, D), can cause serious adverse events. Two water-soluble vitamins, folic acid and niacin, can also have significant toxicities and adverse events.
CONCLUSIONS: Our recommendation is that vitamins A, E, D, folic acid, and niacin should be categorized as over-the-counter medications. Labeling of vitamins, especially those intended for children and other vulnerable groups, should include information on possible toxicities, dosing, recommended upper intake limits, and concurrent use with other products. Vitamin A should be excluded from multivitamin supplements and food fortificants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20040703     DOI: 10.1345/aph.1M238

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  11 in total

1.  Practice of community pharmacists related to multivitamin supplements: a simulated patient study in Iran.

Authors:  Fatemeh Dabaghzadeh; Reza Hajjari
Journal:  Int J Clin Pharm       Date:  2017-12-21

2.  An examination of product packaging marketing strategies used to promote pediatric multivitamins.

Authors:  Danna Ethan; Corey H Basch; Lalitha Samuel; Christine Quinn; Stephanie Dunne
Journal:  J Community Health       Date:  2015-06

3.  Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF.

Authors:  Kacper Wróbel; Anna Justyna Milewska; Michał Marczak; Remigiusz Kozłowski
Journal:  Int J Environ Res Public Health       Date:  2022-07-03       Impact factor: 4.614

Review 4.  Antioxidants for male subfertility.

Authors:  Wiep de Ligny; Roos M Smits; Rebecca Mackenzie-Proctor; Vanessa Jordan; Kathrin Fleischer; Jan Peter de Bruin; Marian G Showell
Journal:  Cochrane Database Syst Rev       Date:  2022-05-04

5.  Complementary and alternative medicine: a survey of its use in pediatric cardiology.

Authors:  Denise Adams; Ashley Whidden; Meeri Honkanen; Simon Dagenais; Tammy Clifford; Lola Baydala; W James King; Sunita Vohra
Journal:  CMAJ Open       Date:  2014-10-01

6.  Serum antioxidant nutrients, vitamin A, and mortality in U.S. Adults.

Authors:  Abhishek Goyal; Mary Beth Terry; Abby B Siegel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-29       Impact factor: 4.254

7.  Antioxidants for male subfertility.

Authors:  Roos M Smits; Rebecca Mackenzie-Proctor; Anusch Yazdani; Marcin T Stankiewicz; Vanessa Jordan; Marian G Showell
Journal:  Cochrane Database Syst Rev       Date:  2019-03-14

8.  Dietary supplement use by older adults with chronic venous leg ulcers: A retrospective, descriptive study.

Authors:  Jodi C McDaniel
Journal:  Wound Repair Regen       Date:  2020-05-04       Impact factor: 3.401

9.  Optimizing chemotherapy: concomitant medication lists.

Authors:  M H Hanigan; B L Dela Cruz; S S Shord; P J Medina; J Fazili; D M Thompson
Journal:  Clin Pharmacol Ther       Date:  2010-12-01       Impact factor: 6.875

10.  CAM use in pediatric neurology: an exploration of concurrent use with conventional medicine.

Authors:  Elaine Galicia-Connolly; Denise Adams; Justin Bateman; Simon Dagenais; Tammy Clifford; Lola Baydala; W James King; Sunita Vohra
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.